Join this channel to get access to perks: Description ================================================ Want to see something ...

The authors organized the threats into a pyramid, with the two extinction-level challenges at the top, followed by the ...

Years ago, well before becoming a CEO, I was a vice president and the only woman on my business unit's senior leadership team ...

Technological advancements in biotechnology and biological sciences are driving transformations across healthcare, ...

Researchers from Columbia University and City College are developing a biohybrid detection system that combines engineered ...

New phase 3b data on Lilly's Taltz and Zepbound advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity: Indianapolis Saturda ...

Meet Zach Frankel, the secretive investor behind Cognition, Ramp• Why techies are hoarding AI compute in their homes• Plus, Recommendations—our weekly pop culture picks: “Bram Stoker’s Dracula,” “The ...

OpenAI's API pricing page now lists gpt-rosalind-discovery, a life sciences model the company hasn't announced. It costs the same as gpt-rosalind-research.

Age reversal has moved from laboratory theory into a real human experiment. ER-100 could help reveal how much of aging biology is actually reversible.

Colossal Biosciences expands its de-extinction platform, linking synthetic biology to conservation, genome engineering, and future healthcare applications.

Colossal Biosciences CEO Ben Lamm says bringing extinct species back can contribute to conservation, healthcare and ...

To do that, he moved to Grand Forks and attended the University of North Dakota, where he earned his degree in 2010.